Clinical Trial: Pharmacokinetic Study of the Use of Nefopam 30 mg Tablets in Patients Suffering From Acute Pain in Rheumatology

U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT07491393) titled 'Pharmacokinetic Study of the Use of Nefopam 30 mg Tablets in Patients Suffering From Acute Pain in Rheumatology' on March 11.

Brief Summary: Nefopam is a non-opioid analgesic approved for the symptomatic treatment of acute pain, particularly postoperative pain. The HAS has authorized nefopam tablet, while emphasizing the lack of bibliographic data on both the pharmacokinetic and clinical aspects.

The aim of this study is to evaluate the pharmacokinetics of nefopam tablets.

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: Acute Rheumatic Pain

Intervention: DRUG: Nefopam administration and prelevment

Catheter ...